HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Goodness-of-fit and local identifiability of a receptor-binding radiopharmacokinetic system.

Abstract
A four-state nonlinear model describing a radiopharmacokinetic system for a hepatic receptor-binding radiopharmaceutical, [99mTc]-galactosyl-neoglycoalbumin (TcNGA), was tested for goodness-of-fit and local identifiability using scanning data from nine healthy subjects and seven patients with severe liver disease. Based on standard deviations of liver and heart imaging data at equilibria as a measure of observational error, the reduced chi-square ranged from 0.5 to 2.6. Values above 1.2 occurred when the subject moved during the 30 min study. Relative standard errors for each parameter were: TcNGA-receptor forward binding rate constant kb, 13-54%; extra-hepatic plasma volume Ve, 0.8-15.0%; hepatic plasma volume Vh, 0.2-6.5%; hepatic plasma flow F, 54----greater than 1000%; and receptor concentration [R]o, 0.3-13%. The highest standard errors occurred when the amount of TcNGA injected exceeded the total amount of receptor. Therefore, when TcNGA functional imaging was performed without excess patient motion and receptor saturation, the kinetic model provided data fits of low systematic error and yielded high precision estimates of receptor concentration and forward binding rate constant. In summary, optimal performance of the kinetic model occurred when the amount of injected TcNGA resulted in the nonlinear operation of the pharmacokinetic system.
AuthorsD R Vera, P O Scheibe, K A Krohn, W L Trudeau, R C Stadalnik
JournalIEEE transactions on bio-medical engineering (IEEE Trans Biomed Eng) Vol. 39 Issue 4 Pg. 356-67 (Apr 1992) ISSN: 0018-9294 [Print] United States
PMID1592401 (Publication Type: Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Albumins
  • Organotechnetium Compounds
  • technetium Tc 99m neogalactoalbumin
Topics
  • Albumins (pharmacokinetics)
  • Binding Sites
  • Evaluation Studies as Topic
  • Humans
  • Liver Diseases (blood, diagnosis, epidemiology)
  • Models, Statistical
  • Organotechnetium Compounds (blood, pharmacokinetics)
  • Pharmacokinetics
  • Reproducibility of Results

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: